Note on the coverage universe. OSS carried a market capitalization of $329.92 million as of the August 6, 2026 close. That is inside our $500 million coverage ceiling, but above $300 million — which makes it a small-cap by the standard FINRA and SEC definition rather than a microcap. We say so plainly rather than let the name of the publication imply otherwise.
What happened
One Stop Systems, Inc. (NASDAQ: OSS) reported second quarter 2026 results before the market opened on August 5, 2026. The following are the reported figures, without interpretation.
Revenue from continuing operations was $9.35 million, against $5.8 million in the same quarter of 2025, an increase of 62.3%. Per the earnings call transcript of the same date, the increase was primarily due to higher sales to a medical imaging original equipment manufacturer of liquid-cooled server products supporting a breast cancer screening application, as that customer moved from prototypes in 2025 into production in 2026.
Bookings were $15.1 million, described by the company as the highest quarterly bookings in its history.
Gross margin was 39.1%, down from 41.3% in the prior-year period, which management attributed on the call to a higher mix of early-stage work.
Loss from continuing operations was $7.7 million, or $0.31 per share, against $4.8 million a year earlier. GAAP net loss from continuing operations was $7.3 million, or $0.29 per share, against $2.5 million, or $0.11 per share, in the prior-year quarter. On a non-GAAP basis the company reported a loss of $0.01 per share.
Full-year 2026 revenue growth guidance was raised to 25% to 30%, from a prior range of 20% to 25%. Gross margin guidance was maintained at approximately 40%.
One structural fact is essential to reading any of the above. Per the company's Q2 commentary, OSS sold its wholly owned subsidiary Bressner in December 2025 for $22.4 million, and Bressner's historical results are now reported as discontinued operations. Zacks reported the year-ago quarter's revenue as $14.11 million on the old consolidated basis. The 62.3% growth figure is real, and it is measured against a base that had a business removed from it.
Verified in a filing versus company-stated. The revenue, margin and loss figures above come from the August 5, 2026 results release and the accompanying earnings call. The Form 10-Q for the quarter had not been reviewed at the time of writing. The bookings figure and the record characterisation are company-stated and are not a GAAP measure, so no filing verifies them independently. Forward guidance is, by definition, company-stated.
Why it matters for a company this size
At roughly $300 million of market value against $9.35 million of quarterly revenue, OSS is priced on the backlog rather than the income statement. That makes the bookings number the load-bearing figure in the release, and it is the one figure with no accounting standard behind it.
The customer concentration point matters more here than it would at scale. A single medical imaging OEM moving from prototype to production accounted for the bulk of a 62.3% revenue increase. At a large company, one customer transitioning is a line item. At this size, it is the growth rate. It cuts both ways: the same concentration that produced the quarter can remove it.
The GAAP to non-GAAP gap is the item that would draw the least attention at a large company and deserves the most here. A GAAP loss of $0.29 per share alongside a non-GAAP loss of $0.01 is a difference of $0.28 per share, which on roughly 25 million shares is around $7 million of excluded costs in a quarter with $9.35 million of revenue. The release accounts for nearly all of it: a $6.25 million charge related to the settlement of a legacy commercial dispute. That is a genuinely non-recurring item, and excluding it from an adjusted figure is the ordinary and defensible use of the measure rather than a way of dressing up operating costs. It also means the quarter carried a real, cash-relevant hit that the one-cent headline does not convey.
What the market reaction tells us
Shares closed at $13.12 on August 5, 2026, down from $14.27 the prior session, a decline of 8.06%. The stock recovered the following day, closing at $13.32 on August 6, up 1.52%. Source: stockanalysis.com and CNN market data, retrieved August 7, 2026.
A beat and raise met with an 8% decline usually means one of two things: the result was already priced, or something inside the release displaced the headline. Both apply here. Per Zacks, OSS shares had risen roughly 98.8% year to date through early August against 13% for the S&P 500, so the bar was high. And the GAAP loss line is the kind of detail that emerges on the call rather than in the first headline.
On volume, the August 6 session traded 1,030,447 shares against a longer-run average above one million. That is an ordinary session, not a repositioning, which argues the decline was a revaluation on the numbers rather than a forced exit. The partial recovery the next day supports the same reading.
What bulls will say
The company has completed a transformation. Selling Bressner left a focused business, described by chief executive Michael Knowles on the August 5 call as a pure-play provider of ruggedized AI and high-performance compute platforms for edge applications. Record bookings of $15.1 million against $9.35 million of revenue is a book-to-bill well above one, which is the leading indicator in a hardware business. The June 16, 2026 announcement of an $8.4 million contract from a defense and technology solutions company, and the July 21, 2026 production order of approximately $2.2 million from an autonomous construction and mining equipment manufacturer against expected cumulative program orders of $10 million, are named, dated, dollar-denominated commitments rather than pipeline language. Management raised guidance, which companies do not do casually. Russell 2000 inclusion on June 29, 2026 broadens the shareholder base.
What bears will say
The growth is one customer deep and the comparison base changed. Gross margin fell 220 basis points while revenue rose 62%, which is the wrong direction for a business claiming operating leverage. The GAAP net loss nearly tripled year over year in the same quarter the company called its strongest ever, and the market is being invited to look at a one-cent non-GAAP loss instead. A company generating roughly $35 million of annualised revenue carrying a market value near $300 million requires the bookings to convert on schedule and at margin, and the 52-week range of roughly $4.19 to $20.86 shows how quickly that assumption gets repriced.
We do not resolve these here. The reconciliation and the 10-Q resolve them.
What to watch next
- The Form 10-Q for the quarter ended June 30, 2026. Specifically the operating expense detail behind the GAAP loss, and the reconciliation to the non-GAAP figure.
- Customer concentration disclosure in the same filing. If a single customer exceeds 10% of revenue, it must be disclosed.
- Third quarter results, expected in early November 2026, and whether the medical imaging OEM ramp repeats or normalises.
- Backlog conversion. Watch whether the $8.4 million defense contract and the mining equipment program orders appear in reported revenue on the timeline management has described.
Sentiment: Neutral. The bookings and the contracts are real and dated. The GAAP loss is also real, and the release attributes the bulk of it to a $6.25 million legacy dispute settlement — a one-time item rather than an operating deterioration. What is left unsettled is whether the order book converts on schedule and at margin, against a business priced near $330 million on roughly $35 million of annualised revenue. That is a question the next two quarters answer, not this one.
VALUATION AT PUBLICATION
One Stop Systems, Inc. (NASDAQ: OSS)
| Field | Figure |
|---|---|
| Share price | $13.32 (USD) |
| Market capitalization | $329.92M, basic |
| Shares outstanding | 24,770,000 |
| Enterprise value | $417.34M as most recently reported, ahead of the Q2 balance sheet |
| Cash and equivalents | $34.37M, most recent reported quarter |
| Total debt | Minimal. Management described the company as carrying no debt on the August 5, 2026 earnings call, consistent with a reported debt to equity ratio of 3.12% |
| 52-week range | $4.17 to $20.88 |
| Average daily volume, in dollars | Approximately $13.7M, shown as inputs: 1,030,447 shares on August 6, 2026 multiplied by $13.32 |
| Exchange and ticker | NASDAQ: OSS |
Price data as of: August 6, 2026 close.
Balance sheet data as of: June 30, 2026, per the Q2 2026 results release dated August 5, 2026.
Price, market capitalization, shares outstanding, 52-week range and volume per stockanalysis.com, retrieved August 7, 2026. Figures are a point-in-time snapshot as of the dates shown and will change. This is not a valuation opinion, a price target, or a recommendation. Income statement figures are drawn from the One Stop Systems second quarter 2026 results release dated August 5, 2026 and the earnings call transcript of the same date. Verify against current data before acting on anything in this piece.
Disclosure
This article is independent editorial content and reflects the author's opinion and analysis as of the date of publication. It is not investment advice and should not be relied on as the basis for any investment decision. MicroCap Desk and its contributors received no compensation of any kind — cash, securities, or otherwise — from any company mentioned, or from any third party, in connection with this article. The author holds no position in any security mentioned. Information is drawn from sources believed reliable but is not guaranteed accurate or complete. Microcap securities carry a high risk of loss. Do your own research. See our full Disclosure.
